Aselizumab(395639-53-9)
- Name: Aselizumab
- Synonyms:Aselizumab
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:395639-53-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.395639-53-9 Research Grade Aselizumab (DHD03301)
Assay:99% Appearance:liquid Package:Inside plastic outside Storage:2-8掳C Transportation:We ship goods via DHL, Fedex, UPS, TNT, China post, NL Post and other couriers, weight from 1g to 1000kg or even bulker Application:Scientific research
Min. Order:1Gram
Supplier:Hebei Nengqian Chemical Import and Export Co., LTD [
China (Mainland)] CAS No.395639-53-9 Aselizumab
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.395639-53-9 Aselizumab
Assay:98%Min Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by ocean shipping or clients requirement Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.395639-53-9 Immunoglobulin G4,anti-(L-selectin) (human-mouse monoclonal HuDreg-55 heavy chain), disulfidewith human-mouse monoclonal HuDreg-55 light chain, dimer (9CI)
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.395639-53-9 Aselizumab
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Aselizumab
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 33697-81-3/3-CHLORO-4-HYDROXYPHENYLACETIC ACID
- 61909-18-0/N,N-dioctyl-N-propyloctan-1-aminium iodide
- 66354-90-3/2-phenyl-3-[(2H-tetrazol-5-ylmethyl)sulfanyl]-1H-indole
- 74789-64-3/bis(2-chloroethyl) [2-(2-benzyl-1H-benzimidazol-1-yl)ethyl]phosphonate
- 139627-48-8/2,3-dipalmitoylglyceric acid
- 69025-03-2/2-(2-hydroxyethyl)-6-[3-(trifluoromethyl)phenoxy]pyridazin-3(2H)-one
- 113614-50-9/cis-3,5-Bis(4-chlorophenyl)-3-((1H-imidazol-1-yl)-methyl)-2-methylisoxazolidine
- 53948-11-1/[3-[(2E)-3,7-Dimethylocta-2,6-dienyl]-2,4-dihydroxy-6-methoxyphenyl]phenylmethanone
- 26088-79-9/2-(4-Acetamidobenzylidene)malononitrile
- 142861-00-5/Herboxidiene
- 68832-78-0/bisperoxo(1,10-phenanthroline)oxovanadate(1-)
- 72681-95-9/Isopalythazine
- 10379-11-0/Nortetrazepam
- 148129-85-5/N,N-dimethyl-1-phenyl-2-(2,3,3-trimethylcyclopent-1-en-1-yl)ethanamine hydrochloride
- 129459-90-1/Benzoic acid, 4-hydroxy-, diphenylsilylene ester
- 68921-68-6/Spinels, aluminum chromium magnesium, mixed with periclase
- 111900-25-5/ciprofibrate-coenzyme A
- 17502-74-8/Spiro(naphthalene-1(2H),3-pyrrolidine)-2,5-dione, 3,4-dihydro-1-(4-(diethylamino)butyl)-7-hydroxy-, hydrochloride
- 395639-53-9/Aselizumab
- 97702-86-8/N-[3-(cyclohexylmethyl)cyclohexyl]acetamide
- 131736-77-1/2-tetradecanoylaminohexanol-1-phosphocholine
- 70692-94-3/MANGANESE ZIRCONIUM OXIDE
- 51354-31-5/17β-Acetyloxy-2α-chloro-5α-androstan-3-one O-(p-nitrophenyl)oxime
- 100231-70-7/Copper,(2-ethylhexanoato-O)(neodecanoato-O)- (9CI)
- 26718-23-0/Ethanamine,2,2'-[(1-methyl-4,4-diphenylbutylidene)bis(4,1-phenyleneoxy)]bis[N,N-diethyl-(9CI)
- 67050-59-3/5-sec-Butyl-5-propylbarbituric acid
- 3365-85-3/4,4''-DIAMINO-P-TERPHENYL
- 5585-14-8/3,4-DIPHENYLFURAZAN2-OXIDE
- 101153-62-2/Pentanoic acid,2-hydroxy-3-methyl-, dodecahydro-8-[[4-O-[(4-hydroxyphenyl)acetyl]-b-D-glucopyranosyl]oxy]-3,6,9-tris(methylene)-2-oxoazuleno[4,5-b]furan-4-ylester (9CI)
- 77872-11-8/3-(1-benzofuran-2-yl)-2,2-dimethylbut-3-enoic acid